Aging, DNA methylation and cancer

Critical Reviews in Oncology/Hematology

Volumn 32, Issue 1, 1999, Pages 31-43

  Issa, Jean Pierre ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE;

AGING; CANCER; CPG ISLAND; DNA METHYLATION; ENZYME ACTIVITY; GENE EXPRESSION SYSTEM; HUMAN; MODEL; PATHOPHYSIOLOGY; REVIEW;

AGING; ANIMALS; CELL AGING; CPG ISLANDS; DNA METHYLATION; HUMANS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL;

EID: 0032845215     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(99)00019-0     Document Type: Review

References (152)

1. Yancik R., Ries L.A. Cancer in older persons. Magnitude of the problem - how do we apply what we know? Cancer. 74(Suppl. 7):1994;1995-2003.
2. Balducci L., Lyman G.H. Cancer in the elderly. Epidemiologic and clinical implications. Clin. Geriatr. Med. 13:1997;1-14.
3. Ershler W.B., Longo D.L. Aging and cancer: issues of basic and clinical science. J. Natl. Cancer Inst. 89:1997;1489-1497.
4. Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer statistics, 1998. CA Cancer J. Clin. 48:1998;6-29.
5. Kinzler K.W., Vogelstein B. Lessons form hereditary colorectal cancer. Cell. 87:1996;159-170.
6. Ames B.N., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA. 90:1993;7915-7922.
7. Warner H.R., Price A.R. Involvement of DNA repair in cancer and aging. J. Gerontol. 44:1989;45-54.
8. Bohr V.A., Anson R.M. DNA damage, mutation and fine structure DNA repair in aging. Mutat. Res. 338:1995;25-34.
9. Dolle M.E., Giese H., Hopkins C.L., Martus H.J., Hausdorff J.M., Vijg J. Rapid accumulation of genome rearrangements in liver but not in brain of old mice. Nat. Genet. 17:1997;431-434.
10. Parsons R., Li G.M., Longley M., Modrich P., Liu B., Berk T., Hamilton S.R., Kinzler K.W., Vogelstein B. Mismatch repair deficiency in phenotypically normal human cells. Science. 268:1995;738-740.
11. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature. 345:1990;458-460.
12. Hastie N.D., Dempster M., Dunlop M.G., Thompson A.M., Green D.K., Allshire R.C. Telomere reduction in human colorectal carcinoma and with ageing. Nature. 346:1990;866-868.
13. Shay J.W. Aging and cancer: are telomeres and telomerase the connection? Mol. Med. Today. 1:1995;378-384.
14. Meeker A.K., Coffey D.S. Telomerase: a promising marker of biological immortality of germ, stem, and cancer cells. A review. Biochemistry (Mosc). 62:1997;1323-1331.
15. Greider C.W. Telomerase activity, cell proliferation, and cancer. Proc. Natl. Acad. Sci. USA. 95:1998;90-92.
16. Blasco M.A., Lee H.W., Hande M.P., Samper E., Lansdorp P.M., DePinho R.A., Greider C.W. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 91:1997;25-34.
17. Baylin S.B., Herman J.G., Graff J.R., Vertino P.M., Issa J.P.J. Alterations in DNA methylation - A fundamental aspect of neoplasia. Adv. Cancer Res. 72:1997;141-196.
18. Jones P.A. DNA methylation errors and cancer. Cancer Res. 56:1996;2463-2467.
19. Smith J.R., Pereirasmith O.M. Replicative senescence - implications for in vivo aging and tumor suppression. Science. 273:1996;63-67.
20. Sager R. Expression genetics in cancer: shifting the focus from DNA to RNA. Proc. Natl. Acad. Sci. USA. 94:1997;952-955.
21. Razin A., Riggs A.D. DNA methylation and gene function. Science. 210:1980;604-610.
22. Adams R.L., Burdon R.H. DNA methylation in eukaryotes. CRC Crit. Rev. Biochem. 13:1982;349-384.
23. Cedar H. DNA methylation and gene activity. Cell. 53:1988;3-4.
24. Razin A, Shemer R. DNA methylation in early development. Hum. Mol. Genet.1995;4: Spec No: 1751-5.
25. Bird A. The essentials of DNA methylation. Cell. 70:1992;5-8.
26. Jost J.P., Saluz H.P., Pawlak A. Estradiol down regulates the binding activity of an avian vitellogenin gene repressor (mdbp-2) and triggers a gradual demethylation of the mCpG pair of its DNA binding site. Nucleic Acids Res. 19:1991;5771-5775.
27. Tornaletti S., Pfeifer G.P. Complete and tissue-independent methylation of cpg sites in the P53 gene: implications for mutations in human cancers. Oncogene. 10:1995;1493-1499.
28. 6-methylguanine-DNA methyltransferase promoter: correlation with gene suppression. Carcinogenesis. 16:1995;1385-1390.
29. 6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells. J. Biol. Chem. 269:1994;17228-17237.
30. Li E., Bestor T.H., Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell. 69:1992;915-926.
31. Walsh C.P., Bestor T.H. Cytosine methylation and mammalian development. Genes Dev. 13:1999;26-34.
32. Weisbrod S. Active chromatin. Nature. 297:1982;289-295.
33. Lewis J., Bird A. DNA methylation and chromatin structure. FEBS Lett. 285:1991;155-159.
34. Haaf T. The effects of 5-azacytidine and 5-azadeoxycytidine on chromosome structure and function: implications for methylation-associated cellular processes. Pharmacol. Ther. 65:1995;19-46.
35. Chen R.Z., Pettersson U., Beard C., Jackson-Grusby L., Jaenisch R. DNA hypomethylation leads to elevated mutation rates. Nature. 395:1998;89-93.
36. Kochanek S., Renz D., Doerfler W. Transcriptional silencing of human Alu sequences and inhibition of protein binding in the box B regulatory elements by 5′-CG-3′ methylation. FEBS Lett. 360:1995;115-120.
37. Kochanek S., Renz D., Doerfler W. DNA methylation in the alu sequences of diploid and haploid primary human cells. EMBO J. 12:1993;1141-1151.
38. Doerfler W. Patterns of DNA methylation - evolutionary vestiges of foreign DNA inactivation as a host defense mechanism. A proposal. Biol. Chem. Hoppe Seyler. 372:1991;557-564.
39. Bestor T.H., Tycko B. Creation of genomic methylation patterns. Nat. Genet. 12:1996;363-367.
40. Antequera F., Bird A. CpG islands. EXS. 64:1993;169-185.
41. Cross S.H., Bird A.P. CpG islands and genes. Curr. Opin. Genet. Dev. 5:1995;309-314.
42. Turker M.S., Bestor T.H. Formation of methylation patterns in the mammalian genome. Mutat. Res. 386:1997;119-130.
43. SingerSam J., Riggs A.D. X-chromosome inactivation and DNA methylation. EXS. 64:1993;358-384.
44. Heard E., Clerc P., Avner P. X-chromosome inactivation in mammals. Annu. Rev. Genet. 31:1997;571-610.
45. Razin A., Cedar H. DNA methylation and genomic imprinting. Cell. 77:1994;473-476.
46. Gartler S.M., Goldman M.A. Reactivation of inactive x-linked genes. Dev. Genet. 15(8):1994;504-514.
47. Barlow D.P. Gametic imprinting in mammals. Science. 270:1995;1610-1613.
48. Li E., Beard C., Jaenisch R. Role for DNA methylation in genomic imprinting. Nature. 366:1993;362-365.
49. Warren S.T., Nelson D.L. Advances in molecular analysis of fragile x syndrome. J. Am. Med. Assoc. 271:1994;536-542.
50. Tate P.H., Bird A.P. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr. Opin. Genet. Dev. 3:1993;226-231.
51. Jones P.L., Veenstra G.J., Wade P.A., Vermaak D., Kass S.U., Landsberger N., Strouboulis J., Wolffe A.P. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19:1998;187-191.
52. Nan X., Ng H.H., Johnson C.A., Laherty C.D., Turner B.M., Eisenman R.N., Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature. 393:1998;386-389.
53. Kass S.U., Pruss D., Wolffe A.P. How does DNA methylation repress transcription? Trends Genet. 13:1997;444-449.
54. Boyes J., Bird A. Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein. EMBO J. 11:1992;327-333.
55. Iguchi-Ariga S.M., Schaffner W. CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation. Genes Dev. 3:1989;612-619.
56. Leonhardt H., Bestor T.H. Structure, function and regulation of mammalian DNA methyltransferase. EXS. 64:1993;109-119.
57. Bestor T., Laudano A., Mattaliano R., Ingram V. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. the carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J. Mol. Biol. 203:1988;971-983.
58. Yen R.W., Vertino P.M., Nelkin B.D., Yu J.J., el-Deiry W., Cumaraswamy A., Lennon G.G., Trask B.J., Celano P., Baylin S.B. Isolation and characterization of the cDNA encoding human DNA methyltransferase. Nucleic Acids Res. 20:1992;2287-2291.
59. Lei H., Oh S.P., Okano M., Juttermann R., Goss K.A., Jaenisch R., Li E. De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development. 122:1996;3195-3205.
60. Yoder J., Bestor T.H. A candidate mammalian DNA methyltransferase related to pmt1p of fission yeast. Hum. Mol. Genet. 7:1998;279-284.
61. Van den Wyngaert I., Sprengel J., Kass S.U., Luyten W.H. Cloning and analysis of a novel human putative DNA methyltransferase. FEBS Lett. 426:1998;283-289.
62. Okano M., Xie S., Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat. Genet. 19:1998;219-220.
63. Romanov G.A., Vanyushin B.F. Methylation of reiterated sequences in mammalian DNAs. Effects of the tissue type, age, malignancy and hormonal induction. Biochim. Biophys. Acta. 653:1981;204-218.
64. Gama-Sosa M.A., Slagel V.A., Trewyn R.W., Oxenhandler R., Kuo K.C., Gehrke C.W., Ehrlich M. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res. 11:1983;6883-6894.
65. Mays-Hoopes L., Chao W., Butcher H.C., Huang R.C. Decreased methylation of the major mouse long interspersed repeated DNA during aging and in myeloma cells. Dev. Genet. 7:1986;65-73.
66. Wilson V.L., Jones P.A. Inhibition of DNA methylation by chemical carcinogens in vitro. Cell. 32:1983;239-246.
67. Poirier L.A. Methyl group deficiency in hepatocarcinogenesis. Drug Metab. Rev. 26:1994;185-199.
68. Kunnath L., Locker J. Characterization of DNA methylation in the rat. Biochim. Biophys. Acta. 699:1982;264-271.
69. Ehrlich M., Zhang X.Y., Wang R.Y. Human DNA methylation: methylated DNA-binding protein, differentiation and cancer. Prog. Clin. Biol. Res. 198(27):1985;255-269.
70. Kanduc D., Ghoshal A., Quagliariello E., Farber E. DNA hypomethylation in ethionine-induced rat preneoplastic hepatocyte nodules. Biochem. Biophys. Res. Commun. 150:1988;739-744.
71. Wilson V.L., Masui T., Smith R.A., Harris C.C. Genomic 5-methyldeoxycytidine decreases associated with the induction of squamous differentiation in cultured normal human bronchial epithelial cells. Carcinogenesis. 9:1988;2155-2159.
72. Hoalvan Helden E.G., van Helden P.D. Age-related methylation changes in DNA may reflect the proliferative potential of organs. Mutat. Res. 219:1989;263-266.
73. Feinberg A.P., Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature. 301:1983;89-92.
74. Feinberg A.P., Vogelstein B. Hypomethylation of ras oncogenes in primary human cancers. Biochem. Biophys. Res. Commun. 111:1983;47-54.
75. Goelz S.E., Vogelstein B., Hamilton S.R., Feinberg A.P. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science. 228:1985;187-190.
76. Deguchi Y., Negoro S., Kishimoto S. Methylation of c-myc gene changes in human lymphoproliferative diseases. Biosci. Rep. 7:1987;637-643.
77. Vedel M., Gomez-Garcia M., Sala M., Sala-Trepat J.M. Changes in methylation pattern of albumin and alpha-fetoprotein genes in developing rat liver and neoplasia. Nucleic Acids Res. 11:1983;4335-4354.
78. Deguchi Y., Negoro S., Hara H., Nishio S., Kishimoto S. Age-related changes of proliferative response, kinetics of expression of protooncogenes after the mitogenic stimulation and methylation level of the protooncogene in purified human lymphocyte subsets. Mech. Ageing Dev. 44:1988;153-168.
79. De Smet C., De Backer O., Faraoni I., Lurquin C., Brasseur F., Boon T. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc. Natl. Acad. Sci. USA. 93:1996;7149-7153.
80. Jeanpierre M., Turleau C., Aurias A., Prieur M., Ledeist F., Fischer A., Viegas-Pequignot E. An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome. Hum. Mol. Genet. 2:1993;731-735.
81. Ji W., Hernandez R., Zhang X.Y., Qu G.Z., Frady A., Varela M., Ehrlich M. DNA demethylation and pericentromeric rearrangements of chromosome 1. Mutat. Res. 379:1997;33-41.
82. Lengauer C., Kinzler K.W., Vogelstein B. DNA methylation and genetic instability in colorectal cancer cells. Proc. Natl. Acad. Sci. USA. 94:1997;2545-2550.
83. Lengauer C., Kinzler K.W., Vogelstein B. Genetic instability in colorectal cancers. Nature. 386:1997;623-627.
84. Laird P.W., Jackson-Grusby L., Fazeli A., Dickinson S.L., Jung W.E., Li E., Weinberg R.A., Jaenisch R. Suppression of intestinal neoplasia by DNA hypomethylation. Cell. 81:1995;197-205.
85. Hammond W.G., Yellin A., Gabriel A., Paladugu R.R., Azumi N., Hill L.R., Benfield J.R. Effects of 5-azacytidine in Syrian golden hamsters: toxicity, tumorigenicity, and differential modulation of bronchial carcinogenesis. Exp. Mol. Pathol. 53:1990;34-51.
86. Kautiainen T.L., Jones P.A. DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture. J. Biol. Chem. 261:1986;1594-1598.
87. Issa J.P., Vertino P.M., Wu J., Sazawal S., Celano P., Nelkin B.D., Hamilton S.R., Baylin S.B. Increased cytosine DNA methyltransferase activity during colon cancer progression. J. Natl. Cancer Inst. 85:1993;1235-1240.
88. Belinsky S.A., Nikula K.J., Baylin S.B., Issa J.P.J. Increased cytosine DNA methyltransferase activity is target-cell specific and an early event in lung cancer. Proc. Natl. Acad. Sci. USA. 93:1996;4045-4050.
89. Szyf M., Kaplan F., Mann V., Giloh H., Kedar E., Razin A. Cell cycle-dependent regulation of eukaryotic DNA methylase level. J. Biol. Chem. 260:1985;8653-8656.
90. Vogel M.C., Papadopoulos T., Muller-Hermelink H.K., Drahovsky D., Pfeifer G.P. Intracellular distribution of DNA methyltransferase during the cell cycle. FEBS Lett. 236:1988;9-13.
91. Szyf M., Bozovic V., Tanigawa G. Growth regulation of mouse DNA methyltransferase gene expression. J. Biol. Chem. 266:1991;10027-10030.
92. Lee P.J., Washer L.L., Law D.J., Boland C.R., Horon I.L., Feinberg A.P. Limited up-regulation of DNA methyltransferase in human colon cancer reflecting increased cell proliferation. Proc. Natl. Acad. Sci. USA. 93:1996;10366-10370.
93. Wu J., Issa J.P., Herman J., Bassett D.E. Jr., Nelkin B.D., Baylin S.B. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. Proc. Natl. Acad. Sci. USA. 90:1993;8891-8895.
94. Vertino P.M., Yen R.W., Gao J., Baylin S.B. De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase. Mol. Cell. Biol. 16:1996;4555-4565.
95. MacLeod A.R., Szyf M. Expression of antisense to DNA methyltransferase mRNA induces DNA demethylation and inhibits tumorigenesis. J. Biol. Chem. 270:1995;8037-8043.
96. Sakai T., Toguchida J., Ohtani N., Yandell D.W., Rapaport J.M., Dryja T.P. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am. J. Hum. Genet. 48:1991;880-888.
97. Merlo A., Herman J.G., Mao L., Lee D.J., Gabrielson E., Burger P.C., Baylin S.B., Sidransky D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med. 1:1995;686-692.
98. Dobrovic A., Simpfendorfer D. Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res. 57:1997;3347-3350.
99. Herman J.G., Latif F., Weng Y., Lerman M.I., Zbar B., Liu S., Samid D., Duan D.S., Gnarra J.R., Linehan W.M., Baylin S.B. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA. 91:1994;9700-9704.
100. Kane M.F., Loda M., Gaida G.M., Lipman J., Mishra R., Goldman H., Jessup J.M., Kolodner R. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 57:1997;808-811.
101. Li Q, Ahuja N, Burger PC, Issa JPJ. Methylation and Silencing of the Thrombospondin-1 Promoter in Human Cancer. Oncogene. 18:1999;3284-3289.
102. Ottaviano Y.L., Issa J.P., Parl F.F., Smith H.S., Baylin S.B., Davidson N.E. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res. 54:1994;2552-2555.
103. Lapidus R.G., Ferguson A.T., Ottaviano Y.L., Parl F.F., Smith H.S., Weitzman S.A., Baylin S.B., Issa J.P.J., Davidson N.E. Methylation of estrogen and progesterone receptor gene 5′ CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors. Clin. Cancer Res. 2:1996;805-810.
104. Myohanen S.K., Baylin S.B., Herman J.G. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res. 58:1998;591-593.
105. Issa J.P., Ottaviano Y.L., Celano P., Hamilton S.R., Davidson N.E., Baylin S.B. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat. Genet. 7:1994;536-540.
106. Issa J.P.J., Baylin S.B., Belinsky S.A. Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure. Cancer Res. 56:1996;3655-3658.
107. Ahuja N., Mohan A.L., Li Q., Stolker J.M., Herman J.G., Hamilton S.R., Baylin S.B., Issa J.P. Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res. 57:1997;3370-3374.
108. Herman J.G., Umar A., Polyak K., Graff J.R., Ahuja N., Issa J.P.J., Markowitz S., Willson J.K.V., Hamilton S.R., Kinzler K.W., Kane M.F., Kolodner R.D., Vogelstein B., Kunkel T.A., Baylin S.B. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. USA. 95:1998;6870-6875.
109. Issa J.P.J., Vertino P.M., Boehm C.D., Newsham I.F., Baylin S.B. Switch from mono-allelic to bi-allelic human IGF2 promoter methylation during aging and carcinogenesis. Proc. Natl. Acad. Sci. USA. 93:1996;11757-11762.
110. Holliday R. The inheritance of epigenetic defects. Science. 238:1987;163-170.
111. Mays-Hoopes L.L. DNA methylation in aging and cancer. J. Gerontol. 44:1989;35-36.
112. Wilson V.L., Jones P.A. DNA methylation decreases in aging but not in immortal cells. Science. 220:1983;1055-1057.
113. Holliday R. Strong effects of 5-azacytidine on the in vitro lifespan of human diploid fibroblasts. Exp. Cell Res. 166:1986;543-552.
114. Rockwell G.A., Johnson G., Sibatani A. In vitro senescence of human keratinocyte cultures. Cell Struct. Funct. 12:1987;539-548.
115. Matsumura T., Hunter J.L., Farooq M., Holliday R. Maintenance of DNA methylation level in SV40-infected human fibroblasts during their in vitro limited proliferative life span. Exp. Cell Res. 184:1989;148-157.
116. Fairweather D.S., Fox M., Margison G.P. The in vitro lifespan of mrc-5 cells is shortened by 5-azacytidine-induced demethylation. Exp. Cell Res. 168:1987;153-159.
117. Holliday R. DNA methylation and epigenetic mechanisms. Cell Biophys. 15:1989;15-20.
118. Singhal R.P., Mays-Hoopes L.L., Eichhorn G.L. DNA methylation in aging of mice. Mech. Ageing Dev. 41:1987;199-210.
119. Wilson V.L., Smith R.A., Ma S., Cutler R.G. Genomic 5-methyldeoxycytidine decreases with age. J. Biol. Chem. 262:1987;9948-9951.
120. Drinkwater R.D., Blake T.J., Morley A.A., Turner D.R. Human lymphocytes aged in vivo have reduced levels of methylation in transcriptionally active and inactive DNA. Mutat. Res. 219:1989;29-37.
121. Rath P.C., Kanungo M.S. Methylation of repetitive DNA sequences in the brain during aging of the rat. FEBS Lett. 244:1989;193-198.
122. Swisshelm K., Disteche C.M., Thorvaldsen J., Nelson A., Salk D. Age-related increase in methylation of ribosomal genes and inactivation of chromosome-specific rRNA gene clusters in mouse. Mutat. Res. 237:1990;131-146.
123. Halle J.P., Schmidt C., Adam G. Changes of the methylation pattern of the c-myc gene during in vitro aging of imr90 human embryonic fibroblasts. Mutat. Res. 316:1995;157-171.
124. Ono T., Tawa R., Shinya K., Hirose S., Okada S. Methylation of the c-myc gene changes during aging process of mice. Biochem. Biophys. Res. Commun. 139:1986;1299-1304.
125. Slagboom P.E., de Leeuw W.J., Vijg J. Messenger RNA levels and methylation patterns of gapdh and beta-actin genes in rat liver, spleen and brain in relation to aging. Mech. Ageing Dev. 53:1990;243-257.
126. Ono T., Shinya K., Uehara Y., Okada S. Endogenous virus genomes become hypomethylated tissue - specifically during aging process of c57bl mice. Mech. Ageing Dev. 50:1989;27-36.
127. Ghazi H., Gonzales F.A., Jones P.A. Methylation of CpG-island-containing genes in human sperm, fetal and adult tissues. Gene. 114:1992;203-210.
128. Ono T., Takahashi N., Okada S. Age-associated changes in DNA methylation and mrna level of the c-myc gene in spleen and liver of mice. Mutat. Res. 219:1989;39-50.
129. Ono T., Yamamoto S., Kurishita A., Yamamoto K., Yamamoto Y., Ujeno Y., Sagisaka K., Fukui Y., Miyamoto M., Tawa R. et al. Comparison of age-associated changes of c-myc gene methylation in liver between man and mouse. Mutat. Res. 237:1990;239-246.
130. Uehara Y., Ono T., Kurishita A., Kokuryu H., Okada S. Age-dependent and tissue-specific changes of DNA methylation within and around the c-fos gene in mice. Oncogene. 4:1989;1023-1028.
131. Lipkin M. Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects. Cancer Res. 48:1988;235-245.
132. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JPJ. Aging and DNA Methylation in Colorectal Mucosa and Cancer. Cancer Res. 1998;58 (in press).
133. Vertino P.M., Issa J.P., Pereira-Smith O.M., Baylin S.B. Stabilization of DNA methyltransferase levels and CpG island hypermethylation precede SV40-induced immortalization of human fibroblasts. Cell Growth Differ. 5:1994;1395-1402.
134. Fujii H., Biel M.A., Zhou W., Weitzman S.A., Baylin S.B., Gabrielson E. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer. Oncogene. 16:1998;2159-2164.
135. Li Q., Jedlicka A., Ahuja N., Gibbons M.C., Baylin S.B., Burger P.C., Issa J.P.J. Concordant Methylation of the ER and N33 genes in Glioblastoma Multiforme. Oncogene. 16:1998;3197-3202.
136. Post WS, Clermont-Goldschmidt PJ, Heldman AW, Sussman MS, Ouyangan P, Milliken, EE, Issa JPJ. Methylation of the Estrogen Receptor Gene in Cardiovascular Tissue is Related to Aging and Atherosclerosis. Cardiovasc Res 1999 (in press).
137. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA. 93:1996;9821-9826.
138. Herman J.G., Merlo A., Mao L., Lapidus R.G., Issa J.P., Davidson N.E., Sidransky D., Baylin S.B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55:1995;4525-4530.
139. Herman J.G., Civin C.I., Issa J.P.J., Collector M.I., Sharkis S.J., Baylin S.B. Distinct Patterns of p15INK4B and p16INK4A Characterize the Major Types of Hematologic Malignancies. Cancer Res. 57:1997;837-841.
140. Migeon B.R., Axelman J., Beggs A.H. Effect of ageing on reactivation of the human X-linked hprt locus. Nature. 335:1988;93-96.
141. Pagani F., Toniolo D., Vergani C. Stability of DNA methylation of X-chromosome genes during aging. Somat. Cell. Mol. Genet. 16:1990;79-84.
142. Chen B., Dias P., Jenkins, 3rd J.J., Savell V.H., Parham D.M. Methylation alterations of the MyoD1 upstream region are predictive of subclassification of human rhabdomyosarcomas. Am. J. Pathol. 152:1998;1071-1079.
143. Morton RA, Jr., Watkins JJ, Bova GS, Wales MM, Baylin SB, Isaacs WB. Hypermethylation of chromosome 17P locus D17S5 in human prostate tissue. J. Urol. 1996;156 (Pt 1): 512-516.
144. Makos M., Nelkin B.D., Lerman M.I., Latif F., Zbar B., Baylin S.B. Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc. Natl. Acad. Sci. USA. 89:1992;1929-1933.
145. Mummaneni P., Bishop P.L., Turker M.S. A cis-acting element accounts for a conserved methylation pattern upstream of the mouse adenine phosphoribosyltransferase gene. J. Biol. Chem. 268:1993;552-558.
146. Mummaneni P., Walker K.A., Bishop P.L., Turker M.S. Epigenetic gene inactivation induced by a cis-acting methylation center. J. Biol. Chem. 270:1995;788-792.
147. Macleod D., Charlton J., Mullins J., Bird A.P. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev. 8:1994;2282-2292.
148. Brandeis M., Frank D., Keshet I., Siegfried Z., Mendelsohn M., Nemes A., Temper V., Razin A., Cedar H. Sp1 elements protect a CpG island from de novo methylation. Nature. 371:1994;435-438.
149. Potter J.D., Bostick R.M., Grandits G.A., Fosdick L., Elmer P., Wood J., Grambsch P., Louis T.A. Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control Study. Cancer Epidemiol. Biomark. Prev. 5:1996;779-784.
150. Kampman E., Potter J.D., Slattery M.L., Caan B.J., Edwards S. Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States. Cancer Causes Control. 8:1997;146-158.
151. Flavell R.B. Inactivation of gene expression in plants as a consequence of specific sequence duplication. Proc. Natl. Acad. Sci. USA. 91:1994;3490-3496.
152. Maloisel L., Rossignol J.L. Suppression of crossing-over by DNA methylation in Ascobolus. Genes Dev. 12:1998;1381-1389.